Essential Drugs Company Limited (EDCL) has entered into a Memorandum of Understanding (MoU) with US-based Dyadic International to locally produce 13 categories of vaccines, including the coronavirus vaccine. The MoU was signed at a ceremony attended by Health and Family Welfare Minister
Under the agreement, Dyadic International will provide technical assistance to EDCL for vaccine production, storage, and quality control in Bangladesh. The vaccine plant will be established in Gopalganj on a nine-acre land, which has already been acquired.
Minister highlighted that this collaboration will enable Bangladesh to manufacture high-standard vaccines, making it one of only five countries worldwide with such capabilities. Once the local demand is met, the country will have the opportunity to export the vaccines to the international market.
The minister emphasized that the foreign partner’s role will focus on providing technical expertise, training, and human resource development to support local manufacturing. This strategic partnership will enhance the country’s self-sufficiency in vaccine production and contribute to the global fight against infectious diseases.